AST-120 in Hemodialysis Patients With Uremic Pruritus

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 2, 2020

Primary Completion Date

August 31, 2022

Study Completion Date

August 31, 2022

Conditions
Uremic Pruritus
Interventions
DRUG

AST-120

If no other medicines are taken usually, take AST-120 one hour after each meal with a frequency of three doses a day and one dose every administration. The drug will be taken for four weeks.

Trial Locations (7)

235

Taipei Tzu Chi Hospital, New Taipei City

433

Tungs' Taichung MetroHarbor Hospital, Taichung

24352

Fu Jen Catholic University Hospital, New Taipei City

33305

Chang-Gung Memorial Hospital, Taoyuan District

81362

Kaohsiung Medical University Hospital, Kaohsiung City

114202

Tri-Service General Hospital, Taipei

407752

Taichung Veterans General Hospital, Taichung

All Listed Sponsors
collaborator

Tri-Service General Hospital

OTHER

collaborator

Tungs' Taichung Metroharbour Hospital

OTHER

collaborator

Chang Gung Memorial Hospital

OTHER

collaborator

Taichung Veterans General Hospital

OTHER

collaborator

Kaohsiung Medical University

OTHER

collaborator

Taichung Tzu Chi Hospital

OTHER

collaborator

Fu Jen Catholic University

OTHER

lead

Conmed Pharmaceutical & Bio-Medical Corporation

INDUSTRY

NCT04639674 - AST-120 in Hemodialysis Patients With Uremic Pruritus | Biotech Hunter | Biotech Hunter